ciprofloxacin has been researched along with chondroitin sulfates in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, JC; Bauer, SA; Glaros, DS; Nirankari, VS | 1 |
| Cho, CS; Cho, KY; Choi, YJ; Kim, MK; Kwon, JW; Lee, JH; Song, HH; Wee, WR; Yoo, MK | 1 |
| Alharbi, NM; Yahya, R | 1 |
3 other study(ies) available for ciprofloxacin and chondroitin sulfates
| Article | Year |
|---|---|
Streptococcus sanguis survival in K-Sol. Comparison of gentamicin and the fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Chondroitin Sulfates; Ciprofloxacin; Colony Count, Microbial; Gentamicins; HEPES; Norfloxacin; Ofloxacin; Streptococcus sanguis | 1991 |
Release of ciprofloxacin from chondroitin 6-sulfate-graft-poloxamer hydrogel in vitro for ophthalmic drug delivery.
Topics: Cells, Cultured; Chondroitin Sulfates; Ciprofloxacin; Drug Carriers; Humans; Hydrogels; Lens, Crystalline; Magnetic Resonance Spectroscopy; Ophthalmic Solutions; Poloxamer; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Temperature | 2005 |
Biosynthesized silver nanoparticles-capped chondroitin sulfate nanogel targeting microbial infections and biofilms for biomedical applications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Chondroitin Sulfates; Ciprofloxacin; Escherichia coli; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Nanogels; Silver; Staphylococcus aureus | 2023 |